The collagen question: what stops your skin making it and what genuinely helps it restart

The biology of collagen decline: what happens after 25 and why it is irreversible without intervention

Collagen is a structural protein produced by fibroblast cells in the dermis, forming a three-dimensional fibril network that supports skin architecture, maintains elasticity and prevents the sagging and wrinkling associated with aging. Human collagen production peaks in the mid-twenties and declines at approximately one percent per year thereafter — a loss rate that is small annually but compounds to twenty percent by age 45 and forty percent by age 60. The primary drivers of this decline are UV radiation (which triggers collagenase enzyme activity that degrades existing collagen faster than fibroblasts can replace it), oxidative stress (which damages fibroblast DNA and reduces their protein synthesis capacity), and hormonal changes (particularly oestrogen reduction, which directly regulates collagen gene expression). Understanding these causes clarifies which interventions have a rational basis: anything that reduces UV damage, oxidative stress or supports fibroblast function is addressing a real driver of collagen decline, not a cosmetic claim.

PDRN as a collagen-stimulating active: the receptor mechanism

PDRN interacts with adenosine A2A receptors expressed on fibroblast cell surfaces. When A2A receptors are activated, they trigger an intracellular signalling cascade that increases fibroblast proliferation rate (more collagen-producing cells) and elevates TGF-β1 expression (a growth factor that directly upregulates collagen type I and III gene transcription). The result is collagen synthesis at a rate above the natural fibroblast production level — effectively reversing the production decline rather than compensating for it cosmetically. PDRN combined with a nine-peptide complex that includes copper tripeptide-1 (which provides copper cofactors required for prolyl hydroxylase, the enzyme that cross-links newly-synthesised collagen strands) covers both collagen production and the cross-linking process that makes new collagen structurally effective.

Glutathione as an oxidative stress reducer that protects existing collagen

While PDRN and peptides focus on increasing collagen production, glutathione addresses the parallel problem of collagen breakdown. Reactive oxygen species (free radicals generated by UV exposure, pollution and metabolic processes) activate matrix metalloproteinase enzymes — the same collagenase enzymes that UV radiation triggers — leading to accelerated collagen degradation independent of the natural production decline. Glutathione, as the primary intracellular antioxidant, neutralises these reactive oxygen species before they can activate the metalloproteinase cascade. A high-concentration glutathione ampoule applied daily reduces the rate of oxidative collagen destruction, preserving the collagen network for longer between synthesis cycles. The brightening effects of glutathione — reducing melanin output as a secondary activity — compound the cosmetic benefit while the anti-oxidative protection operates on the structural level.

EGF and collagen: the epidermal growth factor connection

Epidermal growth factor (EGF) present in certain PDRN ampule formulas contributes to collagen rebuilding through a different pathway than PDRN itself: EGF binds to EGF receptors on keratinocytes and fibroblasts, stimulating cell division and accelerating the turnover of the skin's surface layer. Faster keratinocyte turnover clears the accumulated layer of aged, less-reflective cells that obscures the improved dermal collagen activity — making the results of collagen rebuilding visible at the surface sooner than the dermal process would naturally produce. EGF also signals keratinocyte growth factor production in fibroblasts, creating an indirect additional stimulus for the same fibroblasts that PDRN is activating through the adenosine receptor pathway. The combination of PDRN and EGF in an ampule formula thus activates fibroblast function through two independent signalling pathways.

Realistic expectations from a collagen-rebuilding regimen

Genuine collagen rebuilding takes months — not weeks — because the process involves fibroblast upregulation, collagen synthesis, secretion, and fibril organisation in the dermis before any surface effect becomes visible. The first measurable changes (reduced surface texture irregularity, slight improvement in skin firmness) appear after eight to twelve weeks of consistent twice-daily use of an effective PDRN or peptide treatment. By months four to six, the improvement in structural support becomes perceptible in the way skin holds its position when the face is pressed or folded. Users who measure progress by selfie comparison at weeks two to three and conclude the product is not working are measuring too early and missing the mechanism: the collagen is being built during exactly the period they feel nothing is changing.